From Narcotic to Normalizer: The Misperception of Methadone Treatment and the Persistence of Prejudice and Bias

References

• Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. New York: Springer-Verlag.
   Google Scholar
• Brecher, E. M. & the Editors of Consumer Union Reports. (1972). Licit and illicit drugs: The consumer union report. Boston: Little Brown and Company.
   Google Scholar
• Dole, V. P. (1970). Biochemistry of addiction. Annual Review of Biochemistry, 39, 821–840.
   Google Scholar
• Dole, V. P. (1988). Implications of methadone maintenance for the theories of narcotic addiction. Journal of the American Medical Association, 260(20), 3025–3029.
   Google Scholar
• Dole, V. P. (1994). What have we learned from three decades of methadone maintenance treatment? Drug Alcohol Review, 13(1), 3–4.
   Google Scholar
• Dole, V. P., & Joseph, H. (1978). Long-term outcome of patients treated with methadone maintenance. Annals of the New York Academy of Sciences, 311, 181–196.
   Google Scholar
• Dole, V. P., & Kreek, M. J. (1973). Methadone plasma level: Sustained by a reservoir of drug in tissue. Proceedings of the National Academy of Science USA, 70(1), 10.
   Google Scholar
• Dole, V. P., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association, 193(8), 646–650.
   Google Scholar
• Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction: A metabolic disease. Archives of Internal Medicine, 120, 19–24.
   Google Scholar
• Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118, 304–309
   Google Scholar
• Galynker, I. I., Watras-Ganz, S., Minter C., Rosenthal R. N., DesJarlais D. C., Richman B. L., & London, E. (2000). Cerebral metabolism in opiate-dependent subjects: Effects of methadone maintenance. Mount Sinai Journal of Medicine, 67(5&6), 381–387.
   Google Scholar
• Gearing, F. R., & Schweitzer, M. D. (1974). An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. American Journal of Epidemiology, 100(2), 101–12.
   Google Scholar
• General Accounting Office. (1990). Methadone maintenance: Some treatment programs are not effective; greater federal oversight needed. Rockville, Maryland: U.S. Govt. Printing Office. GAO/HRD-90-104.
   Google Scholar
• Goldstein, A., Lowney, L. I., & Pal, B. K. (1971). Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proceedings National Academy Science USA, 68, 1742–1747.
   Google Scholar
• Gordon, N. B. (1973). The functional status of the methadone maintained person. In L. R. S. Simmons & M. B. Gold, Discrimination and the Addict (pp 101–121). New York: Sage Publications, 1973.
   Google Scholar
• Gordon, N. B. (1994). The functional potential of the methadone maintained person. Methadone treatment works: A compendium for methadone maintenance treatment. Monograph Series No. 2., Chemical Dependency Research Working Group. Available from NYS Office of Alcoholism and Substance Abuse Services: New York.
   Google Scholar
• Gordon, N. B., & Appel, P. A. (1995). Functional potential of the methadone maintained patient. Alcohol Drugs and Driving, 11(1), 31–37.
   Google Scholar
• Hartel, D., Selwyn, P. A., & Schoenbaum, E. E. (1988). Methadone maintenance treatment and reduced risk of AIDS and AID-specific mortality in intravenous drug users. Presented at the IV International Conference on AIDS; June 8–14. No. 8546. Stockholm, Sweden.
   Google Scholar
• Himmelsbach, C. (1968). Clinical studies of morphine addictions. Proceedings of the 49th Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Harris, L. S. (ed.). Rockville, Maryland: U.S. Dept. of Health and Human Services. National Institute on Drug Abuse. Research Monograph Series 81. Nathan B. Eddy Memorial Award Lecture.
   Google Scholar
• Ingolia, N. A., & Dole, V. P. (1970). Localization of d and l-methadone after intraventricular injection into rat brains. Journal of Pharmacology and Experimental Therapeutics, 175, 84–87.
   Google Scholar
• Institute of Medicine. (1995). Federal regulation of methadone treatment. R. A. Rettig, A. Yarmolinsky (eds.). Washington, DC: National Academy Press.
   Google Scholar
• Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment: A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5&6), 345–346.
   Google Scholar
• Kreek, M. J. (1973a). Medical safety and side effects of methadone in tolerant individuals. Journal of the American Medical Association, 223(6), 665–668.
   Google Scholar
• Kreek, M. J. (1973b). Plasma and urine levels of methadone. New Yok State Journal of Medicine, 73(23), 2773–2777.
   Google Scholar
• Kreek, M. J. (1978). Medical complications in methadone patients. Annals of the New York Academy of Sciences, 311, 110–134.
   Google Scholar
• Kreek, M. J. (2000). History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences, 909, 186–216.
   Google Scholar
• Kreek, M. J. (2007). Opioids, dopamine, stress, and the addictions. Dialogues in Clinical Neuroscience, 9(4), 363–378.
   Google Scholar
• Kreek, M. J., Oratz, M., & Rothschild, M. A. (1978). Hepatic extraction of long- and short-acting narcotics in the isolated perfused rabbit liver. Gastroenterology, 75, 88–94.
   Google Scholar
• Kreek, M. J., Bart, G., Lilly, C., LaForge, K. S., & Nielsen, D. A. (2005). Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacological Review, 57(1), 1–26.
   Google Scholar
• Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S. (2005). Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience, 8, 1450–1457.
   Google Scholar
• Li, M. D., & Burmeister, M. B. (2009). New insights into the genetics of addiction. National Review Genetics, 10, 225–231.
   Google Scholar
• Magura, S., Nwakeze, P. C., & Demsky, S.Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51–60.
   Google Scholar
• Magura, S., Nwakeze, P. C., Kang, S. Y., & Demsky, S. (1999). Program quality effects on patient outcomes during methadone maintenance: A study of 17 clinics. Substance Use and Misuse, 34(9), 1299–1324.
   Google Scholar
• Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine, 68(1), 62–74.
   Google Scholar
• Martin, W. R., & Jasiniski, D. R. (1969). Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence. Journal of Psychiatric Research, 1, 9–17.
   Google Scholar
• Martin, W. R., Wilker, A., Eades, G. C., & Pescor, F. T. (1963). Tolerance and physical dependence on morphine in rats. Psychopharmacology, 4, 247–260.
   Google Scholar
• Minozzi, S., Amato, L., & Davoli, M. (2013). Development of dependence following treatment with opioid analgesics for pain relief: A systematic review. Addiction, 108, 688–698.
   Google Scholar
• National Institute of Health. (1997). Effective Medical Treatment of Opiate Addiction. Consensus Development Conference Statement. Number 108 (November 17–19). NIH Consensus Statement 15(6), 1–38.
   Google Scholar
• Newman, R. G., & Cates, M. (1977). Methadone treatment in narcotic addiction: Program management, findings and prospects for the future. New York: Academic Press.
   Google Scholar
• Pert, C. B., & Snyder, S. H. (1973). Opiate receptor: Demonstration in nervous tissue. Science 179, 1011–4.
   Google Scholar
• Rounsaville, B. J., Weissman, M. M., Crits-Christoph, K., Wilber, C., & Kleber, H. (1982). Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Archives General Psychiatry, 39, 151–156.
   Google Scholar
• Simon, E. J., Hiller, J. M., & Edelman, I. (1973). Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenates. Proceedings National Academy Science USA, 70, 1947–1949.
   Google Scholar
• Stimmel, B., & Kreek, M. J. (2000). Neurobiology of addictive behaviors and its relationship to methadone maintenance. Mount Sinai Journal of Medicine, 67(5–6), 375–80.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). (1991). State Methadone. Treatment. Guidelines. Treatment Improvement Protocol (TIP 1). Mark W. Parrino, M.P.A., Consensus Panel Chair. US. DEPARTMENT of Health and Human Services. (SMA 93–1991).
   Google Scholar
• Terenius, L. (1973). Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacology Toxicology,32(3), 317–320.
   Google Scholar
• United States Congress, Senate. (2000). Drug Addiction and Treatment Act (DATA), Title XXXV, Section 3502 of the Children's Health Act. H.R. 2634. 106th Congress, 2nd Session; Washington.
   Google Scholar
• Van den Bree, M., Johnson, E., Neale, M., & Pickens, R. (1998). Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug and Alcohol Dependence 52(3), 231–241.
   Google Scholar
• Watters, J. A., & Price, R. H. (1985). The relationship of treatment policy to client retention. In P. Appel (Eds.), Treatment Issue Report #56, Unpublished internal report. New York: New York State Division of Substance Abuse Services.
   Google Scholar
• Zadina, J. E., Chang, S. L., Ge, L. J., & Kastin, A. J. (1993). Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. Journal of Pharmacology and Experimental Therapeutics, 265(1), 254–262.
   Google Scholar